Berlin-Buch. Clinical research

Experimental and Clinical Research Center (ECRC)
Robert-Rössle-Str. 10, 13125 Berlin
	Direktor des ECRC am MDC:
	Prof. Dr. med. Friedrich C. Luft
	(030) 450 540 002
	(030) 450 540 900
	luft@charite.de
	Kaufmännische Leiterin:
	Dr. Regina Jünger
	(030) 450 540 011
	(030) 450 540 902
	regina.juenger@charite.de
	www.charite.de/en/research/

Profil: Since early 2007, the Charité and the Max Delbrück Center for Molecular Medicine (MDC) on the Campus Berlin-Buch have jointly operated a translational research center, the Experimental and Clinical Research Center (ECRC).

The goal of the ECRC is to most efficiently transform research findings into clinical applications. Inpatient medical care is provided by the HELIOS Kliniken GmbH. On the Berlin-Buch campus Charité research focuses on:

Surgical Oncology (Prof. Peter Schlag)

Hematology, Oncology and Tummorimmunology (Prof. Bernd Dörken)

Molecular and Clinical Cardiology (Prof. Rainer Dietz)

Nephrology and Hypertensiology (Prof. Friedrich Luft)

Molecular Neurology (Prof. Frauke Zipp)

HELIOS Research Center GmbH (HRC)
Friedrichstr. 136, 10117 Berlin
	Chief executives:
	PD Dr. med. Parwis Fotuhi Prof. Dr. med. Petra Thürmann Dr. Francesco De Meo
	(030) 521 321 350
	(030) 521 321 199
	kerstin.zerdick@helios-kliniken.de

Profil:

The advancement of science and research plays a crucial role within the HELIOS Clinics group. In order to be able to promote this field in as targeted and efficient a manner as possible, in March 2002 HRC GmbH was set up as a daughter company of HELIOS Klinikum GmbH. The HRC sees itself as a mediator and interface between the scientific activities of HELIOS members of staff and external interested parties as far as opportunities for carrying out clinical trials or research projects are concerned. The Research Center supports research and other scientific staff using the funding obtained from clinical studies and their professional execution. This allows the researchers to concentrate on their projects. The HELIOS Research Center GmbH receives 76% of its support from HELIOS Klinikum GmbH and 24% from the Max Delbrück Center for Molecular Medicine (MDC) Berlin-Buch.